title: What should a new thrombolytic bring us?
authors.affiliation: Department of Cardiology, Academisch Ziekenhuis Nijmegen, The Netherlands.
authors.forename: F
authors.initials: F
authors.lastname: Verheugt
mesh_terms: D002543:Cerebral Hemorrhage / Q000209:etiology; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods*
chemical_list: D005343:Fibrinolytic Agents